In a terrifying incident in Los Angeles, a vehicle rammed into a crowd outside a nightclub, injuring 30 people. Eyewitnesses report chaos as bystanders confronted the driver, who was later found shot.
This weekend, Superman is set to lead the box office with impressive projections while new releases like I Know What You Did Last Summer and Smurfs vie for attention. Will Superman maintain its reign?
A 61-year-old man has tragically died after being pulled into an MRI machine while wearing a metal chain. The incident occurred in Westbury, NY, raising serious safety concerns about MRI protocols.
During her San Francisco concert, Katy Perry's giant butterfly prop malfunctioned, dropping several feet mid-performance. Despite the scare, Perry recovered quickly and continued her show. She later joked about the incident on Instagram.
The first reactions to Marvel's 'The Fantastic Four: First Steps' are in, with critics praising its stunning visuals and confident storytelling. Pedro Pascal and Vanessa Kirby shine in this epic adventure set to hit theaters on July 24.
In a devastating incident, 32 Palestinians seeking aid were killed by Israeli gunfire near distribution points in southern Gaza. Eyewitnesses describe the gunfire as targeted, raising serious humanitarian concerns.
An early morning incident in East Hollywood left at least 30 people injured when a vehicle drove into a crowd. Seven victims are critically injured, and many others received treatment on the scene.
The second-quarter earnings season has kicked off with impressive corporate profits driven by consumer strength, but the stock market's muted response raises concerns about investor expectations. Despite a stellar 94.4% earnings beat rate in financials, stocks remain stagnant.
In a shocking revelation, Tulsi Gabbard accuses Obama and senior officials of a treasonous conspiracy aimed at undermining Trump’s presidency. She calls for their prosecution, alleging they manipulated intelligence assessments during the 2016 election.
In a stunning move, the FDA has put clinical trials for Sarepta's gene therapy on hold due to alarming safety concerns after multiple patient deaths linked to acute liver failure. The company faces scrutiny as it navigates the fallout.
